Evidence map›Paper›PMID 37047193›Full record

ArticleInternational journal of molecular sciences2023

Protective Effect of

Alex De Gregorio, Annalucia Serafino, Ewa Krystyna Krasnowska, Fabiana Superti, Maria Rosa Di Fazio, Maria Pia Fuggetta, Ivano Hammarberg Ferri, Carla Fiorentini

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Viable and Heat-InactivatedMicroorganisms · 2026
    Article
  2. Article
  3. Review
  4. Collection of human bacteria at University of Tartu, Estonia.Microbiology resource announcements · 2026
    Article
  5. International journal of molecular sciences · 2025
    Article
  6. miR-539-5p Regulates Irritable Bowel Syndrome Pathological Processes by Targeting KDM6A.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Probiotics: Shaping the gut immunological responses.World journal of gastroenterology · 2024
    Article
  12. Article
  13. Article
  14. Translational animal science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alex De GregorioInstitute of Translational Pharmacology, National Research Council of Italy (CNR), Via Fosso del Cavaliere 100, 00133 Rome, Italy.ORCID 0000-0002-6560-293X
Annalucia SerafinoInstitute of Translational Pharmacology, National Research Council of Italy (CNR), Via Fosso del Cavaliere 100, 00133 Rome, Italy.
Ewa Krystyna KrasnowskaInstitute of Translational Pharmacology, National Research Council of Italy (CNR), Via Fosso del Cavaliere 100, 00133 Rome, Italy.ORCID 0000-0001-9137-5446
Fabiana SupertiNational Centre for Innovative Technologies in Public Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.ORCID 0000-0003-4909-7598
Maria Rosa Di FazioSH Outpatient Oncology Clinic, Via dei Paceri 86/A, 47891 Falciano, San Marino.
Maria Pia FuggettaInstitute of Translational Pharmacology, National Research Council of Italy (CNR), Via Fosso del Cavaliere 100, 00133 Rome, Italy.
Ivano Hammarberg FerriAssociation for Research on Integrative Oncology Therapies (ARTOI) Foundation, Via Ludovico Micara, 73, 00165 Rome, Italy.
Carla FiorentiniAssociation for Research on Integrative Oncology Therapies (ARTOI) Foundation, Via Ludovico Micara, 73, 00165 Rome, Italy.ORCID 0000-0003-1707-6282
Istituto di Farmacologia Traslazionale · ITIstituto Superiore di Sanità · IT

Funding

Association for Research on Integrative Oncology Therapies (ARTOI) Foundation Funding to C.F. and I.H.F.Essential Integratori S.r.l., Bologna, Italy Funding to I.H.F.Institute of Translational Pharmacology CNR Departmental Projects DSB.AD007.295.001 to A.S.; DSB.AD007.295.003 to M.P.F.
6 · The paper itself

Abstract

Chemotherapy- or inflammation-induced increase in intestinal permeability represents a severe element in disease evolution in patients suffering from colorectal cancer and gut inflammatory conditions. Emerging data strongly support the gut microbiota's role in preserving intestinal barrier integrity, whilst both chemotherapy and gut inflammation alter microbiota composition. Some probiotics might have a strong re-balancing effect on the gut microbiota, also positively affecting intestinal barrier integrity. In this study, we asked whether

Indexed as

Limosilactobacillus fermentumCaco-2 CellsHumansInflammationIntestinal MucosaLipopolysaccharidesPermeabilityTight JunctionsLipopolysaccharideschemotherapycolon cancerdysbiosisLimosilactobacillus fermentum ME-3®membrane permeabilitytight junctions

Identifiers

PMID37047193
PMCPMC10094186
OpenAlexW4361018925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.